title: Anaemia as an inflammation-mediated condition during chronic heart failure. Possible role of fibrinogen.
abstract: BACKGROUND
  In patients with chronic heart failure (CHF) anaemia is a common finding and may worsen clinical conditions. Moreover, CHF itself could be involved in the pathogenesis of anaemia. Early studies suggested a pathogenic role of inflammation mediators.
  
  
  OBJECTIVE
  The objectives of the study were to assess the relationship between CHF and haemoglobin (Hgb) plasma levels, and to investigate a possible link between fibrinogen plasma levels and anaemia.
  
  
  METHODS
  This retrospective study included consecutively hospitalized patients with CHF and left ventricular ejection fraction (LVEF) < 50%. Patients without signs or symptoms of CHF and with LVEF > or = 50% were selected as controls. Patients with secondary anaemia were excluded.
  
  
  RESULTS
  257 patients (72% men) with CHF and 224 controls (65% men) were studied.The average +/- SD of Hgb in CHF patients was 12.38 +/- 1.98 g/dl vs. 13.43 +/- 1.64 g/dl in controls (P < 0.0001). A total of 69 patients (26.7%) had both CHF and anaemia. Plasma fibrinogen concentration was higher in the patients compared with the control subjects (364.83 +/- 123.76 mg/dl vs. 343.44 +/- 135.43 mg/dl; respectively; P = 0.013). Patients with anaemia showed a significantly higher plasma fibrinogen concentration compared to those without anaemia (400.57 +/- 132.36 mg/dl vs. 351.72 +/- 118.13 mg/dl; P = 0.0059). Stepwise logistic regression analysis showed that female gender, creatinine plasma levels, and fibrinogen plasma levels were independently associated with anaemia. No significant relationship between fibrinogen and creatinine plasma concentration was found.
  
  
  CONCLUSIONS
  Anaemia is common in CHF patients and it is associated with heart failure severity.The increase of fibrinogen plasma levels in CHF patients seems to confirm that chronic inflammation is involved in the pathogenesis of anaemia.
authors.affiliation: Dept. of Internal Medicine, University La Sapienza, Roma, Italy. sergio.morelli@uniroma1.it
authors.forename: Sergio
authors.initials: S
authors.lastname: Morelli
authors.forename: Fabiana
authors.initials: F
authors.lastname: Di Girolamo
authors.forename: Alessandra
authors.initials: A
authors.lastname: Angelino
authors.forename: Francesca
authors.initials: F
authors.lastname: Fravolini
authors.forename: Carmine
authors.initials: C
authors.lastname: Mancusi
authors.forename: Veronica
authors.initials: V
authors.lastname: Diurni
authors.forename: Raffaella
authors.initials: R
authors.lastname: Molfetta
authors.forename: Cristina
authors.initials: C
authors.lastname: Acconcia
authors.forename: Francesco
authors.initials: F
authors.lastname: Balsano
mesh_terms: D000368:Aged; D000740:Anemia / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D016022:Case-Control Studies; D002908:Chronic Disease; D005260:Female; D005340:Fibrinogen / Q000378:metabolism*; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007249:Inflammation / Q000150:complications* / Q000503:physiopathology; D007558:Italy / Q000453:epidemiology; D016015:Logistic Models; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors; D013318:Stroke Volume; D016277:Ventricular Function, Left
chemical_list: D005340:Fibrinogen